Australia Patient Support Program (PSP) Market Analysis

1. A sample report on Australia Patient Support Program Market Analysis Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2021 – 2030F) www.insights10.com

2. This report presents a strategic analysis of the Australia Patient Support Program market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, characteristics, main players, trends and insights, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Australia Patient Support Program market, and offers unmatched value, accuracy, and expert insights

3. • Market Overview • Growth Drivers & Restraints • Market Segmentation • Major Market Share • Competitive Landscape • Key Company Profiles • Healthcare Policies & Regulatory Framework • Factors Driving Future Growth • Future Opportunities • Conclusion Table of Contents

4. Table of Contents 1. Australia Patient Support Program Market Overview………………..……….……………………………....................................6 1.1 Market size and forecast 1.2 Patient support programs: What do they offer? 2. Market Growth Drivers and Restraints …………………………………………………………………….…………….…………….9 2.1 Market Growth Drivers 2.1.1 Rising number of collaborations and partnerships between stakeholders 2.1.2 Increasing adoption of digital therapeutics and remote monitoring solutions 2.1.3 Implementation of government regulations and initiatives to promote patient-centric care 2.2 Market Restraints 2.2.1 Patient needs are unique and vary by region 2.2.2 Formulary restrictions and cost-sharing 3. Market Segmentation……………………………………………………………….…………………..…………………..………….….15 3.1 By caregiver access 3.2 By healthcare financing 4 A Sample Report on Australia Patient Support Program Market I Confidential

5. Table of Contents (continued) 4. Major Products Market Share………………………..…………………………………………………………………..…………....…19 4.1 Market analysis, insights and forecast - By revenue 5. Competitive Landscape……………………………………………………..……………………...…………..…................................21 5.1 Major companies for Australia market 6. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ……………………..…….......23 6.1 AstraZeneca 6.2 GSK 6.3 Abbvie 6.4 Vaitris 7. Healthcare Policies and Regulatory Landscape…………………………………………………….……………………..………....28 7.1 Regulatory framework of Australia patient support program market 8. Factors Driving Future Growth………………………………………………………………………………………………..………....30 8.1 Recent developments in patient support program 9. Future Opportunities…………………..…………..………………………………….………………………………………………......32 9.1 Future Opportunities 10. Conclusion……………………………..…………..………………………………….………………………………………………......34 5 A Sample Report on Australia Patient Support Program Market I Confidential

6. Australia Patient Support Program Market Analysis 1. Overview

7. 1.1 Market size & forecast Key Analysis Australia Patient Program Market Forecast (2022-2030F) Australia Patient Support Program (PSP) stood at around USD XX Bn in 2021 and is projected to reach USD XX Bn by 2030, exhibiting a CAGR of XX % during the forecast period ▪ $ XX Pharmaceutical companies play a key role in supporting the quality use of medicines through patient focused programs. These programs are designed to aid compliance and lifestyle choices ▪ $ XX PSPs provide significant value to patients through the accessibility of information and support and the participation is only available to patients who have been already prescribed a medicine and supported by their healthcare professional ▪ SAMPLE 7 A Sample Report on Australia Patient Support Program Market I Confidential

8. 1.2 Patient support programs: What do they offer? Patient Support Programs (PSPs) Patient Access Programs Patient Adherence Programs Convenience Programs Financial Assistance Programs Named Patient Programs (NPP) Patient Education Programs Other Support Programs Loyalty Programs 8 A Sample Report on Australia Patient Support Program Market I Confidential

9. Australia Patient Support Program Market Analysis 2. Growth Drivers & Restraints

10. Market growth drivers and restraints Drivers Increasing adoption of digital therapeutics and remote monitoring solutions Implementation of government regulations and initiatives to promote patient-centric care Rising number of collaborations and partnerships between stakeholders Restraints Patient needs are unique and vary by region Formulary restrictions and cost-sharing 10 A Sample Report on Australia Patient Support Program Market I Confidential

11. 2.1 Market growth drivers 2.1.1 Rising number of collaborations and partnerships between stakeholders As many patient organizations work with pharma industry on various different levels – from knowledge sharing to financial support – it is key to shape those relationships in a transparent way ▪ 11 A Sample Report on Australia Patient Support Program Market I Confidential

12. Market growth drivers (continued) 2.1.2 Increasing adoption of digital therapeutics and patient engagement solutions Increasing trend of delivering patient engagement experiences across digital marketing channels to interact with patients, helping them stay engaged with their health ▪ Increasing use of digital technology in the patient support program helps patient and the care giver to track the health condition including the proper guidance to patient whenever and wherever required ▪ 12 A Sample Report on Australia Patient Support Program Market I Confidential

13. Market growth drivers (continued) 2.1.3 Implementation of government regulations and initiatives to promote patient-centric care Favorable government initiatives are likely to impact market growth in the coming years. The Australian government has clearly defined the patient support programs having an objective of the healthcare and well- being of the patients including the emotional as well as the financial support ▪ 13 A Sample Report on Australia Patient Support Program Market I Confidential

14. 2.2 Market restraints 2.2.2 Formulary restrictions and cost- sharing 2.2.1 Patient needs are unique and vary by regions There is opportunity to leverage learnings, but there’s no plug-and-play method when it comes to PSPs More than half faced a formulary restriction, and some abandoned due to cost ▪ ▪ For launch and mature brands alike, that access increasingly comes with higher patient cost- sharing and utilization restrictions such as prior authorization and step therapy ▪ What is successful for one product in one region, will struggle to be directly lifted into a new region namely because across countries and regions the patient journey will differ ▪ 14 A Sample Report on Australia Patient Support Program Market I Confidential

15. Australia Patient Support Program Market Analysis 3. Market Segmentation

16. Australia patient support program market segmentation Patient Support Program Market Segmentation Caregiver Access Healthcare Financing Virtual Care/ Telehealth Benefit Coverage (BI/PA/Appeal) Remote Monitoring Co-pay assistance Healthcare at Home Alternative Coverage / PAPs Patient Transportation Reimbursement Support Health Coaching 16 A Sample Report on Australia Patient Support Program Market I Confidential

17. 3.1 Market segmentation: By caregiver access Patient Support Program Market Share by Caregiver Access (2021) Key Insights Remote patient monitoring enables monitoring of patients outside conventional clinical settings thereby increasing access to care and reducing healthcare delivery costs ▪ Home healthcare is a supportive care provided by medical professionals at patient’s home for the purpose of promoting, maintaining or restoring health or maximizing the level of independence while minimizing the effects of disability and illness ▪ Virtual Care/ Telehealth Remote Monitoring Healthcare at Home Patient Health Coaching Transportation 17 A Sample Report on Australia Patient Support Program Market I Confidential

18. 3.2 Market segmentation: By healthcare financing Patient Support Program Market Share by Healthcare Financing (2021) Key Insights Electronic Prior Authorization (ePA)- it is the electronic transmission of information between the prescriber, and payer to determine whether or not the PA is granted ▪ Reimbursement Support - Services remove barriers to successful payment of claims and provide a resource for patients with coverage-related questions ▪ Benefit Coverage (BI/PA/Appeal) Co-pay Assistance Alternative Coverage / PAPs Reimbursement Support 18 A Sample Report on Australia Patient Support Program Market I Confidential

19. Australia Patient Support Program Market Analysis 4. Major Market Share

20. 4.1 Major patient support program operators Key Insights From the pharmaceutical company’s perspective, PSPs contribute to better patient outcomes overall, and as the industry shifts more toward outcomes-based payment models, enhancing actual patient outcomes will be a crucial success element ▪ A strong patient support program will influence the approval of treatments and market authorizations and will boost patient enrollment ▪ 20 A Sample Report on Australia Patient Support Program Market I Confidential

21. Australia Patient Support Program Market Analysis 5. Competitive Landscape

22. 5.1 Major players revenue (current and forecast) Major Market Revenue of Patient Support Services Companies ($Bn) Key Insights SAMPLE AstraZeneca GSK Abbvie Viatris Revenue share used for PSP Other revenue 22 A Sample Report on Australia Patient Support Program Market I Confidential

23. Australia Patient Support Program Market Analysis 6. Key Company Profiles

24. 6.1 AstraZeneca Company Overview Company at a Glance • The AstraZeneca Patient Support Programs help patients navigate the complexities of reimbursement and provide support during the journey of their treatment Company Name: AstraZeneca • Connect360, AstraZeneca Oncology patient support programs are some of the PSPs going on currently Year of Establishment: 1999 Headquarter: Cambridge, US Revenue (EU): $37.4 Bn (2021) Website: www.astrazeneca.com 24 A Sample Report on Australia Patient Support Program Market I Confidential

25. 6.2 GSK Company Overview Company at a Glance • GSK has patient support program named NuYou Support that is being offered to the Australian patients Company Name: GSK • GSK provides the access to its Asthma drugs Nucala and the access to helpful resources for treatment in Australia Year of Establishment: 2000 Headquarter: Brentford, UK Revenue (EU): $33.3 Bn (2021) Website: www.gsk.com/en-gb/ 25 A Sample Report on Australia Patient Support Program Market I Confidential

26. 6.3 Abbvie Company Overview Company at a Glance • In Australia Abbvie have created patient support programs that currently benefit more than 14,000 patient lives and help support them for better health outcomes Company Name: Abbvie • AbbVie’s patient support and services go far beyond basic disease information with support programs that enable them to remain as active and independent as possible and ensure optimal care Year of Establishment: 2013 Headquarter: Illinois, US Revenue (EU): $14.8Bn (2021) Website: www.abbvie.com/ 26 A Sample Report on Australia Patient Support Program Market I Confidential

27. 6.4 Viatris Company Overview Company at a Glance Viatris has MyEpiPen® Patient Support Program for Australian patients. Australia’s 35,000-member EpiClub® program has been revamped and rebranded by Viatris (formerly Mylan) as the MyEpiPen® Patient Support Program • Company Name: Viatris Year of Establishment: 1961 Headquarter: Pennslyvania, US Revenue (EU): $11.9 Bn (2021) Website: www.viatris.com 27 A Sample Report on Australia Patient Support Program Market I Confidential

28. Australia Patient Support Program Market Analysis 7. Healthcare Policy and Regulatory Landscape

29. 7.1 Regulatory framework of Australia patient support program market ▪ The Department of Health in Australia has defined as - The healthcare and wellbeing of patients must be the only objective of a Patient Support Program ▪ Rules and key pointers: ▪ Any payments should be included in the company’s reporting of financial support, grants etc. in the interests of being open and transparent about the conduct and management of a PSP ▪ In relation to data that is collected in a Patient Support Program, the Department suggests there should be further clarification of the types of information that can be communicated to healthcare professionals 29 A Sample Report on Australia Patient Support Program Market I Confidential

30. Australia Patient Support Program Market Analysis 8. Factors Driving Future Growth

31. 8.1 Recent developments in patient support program Pharma manufacturers often use training materials to create awareness for these programs, a channel growing in popularity is actively participating in the patient journey — more specifically, connectivity with electronic health records (EHRs) systems to augment education. These integrations builds improved awareness for providers, growing program adoption ▪ As more specialty products come to the market, compressing onboarding time through technology solutions for both prior authorizations and electronic benefits investigations will ensure patients get on (and stay on) therapies ▪ 31 A Sample Report on Australia Patient Support Program Market I Confidential

32. Australia Patient Support Program Market Analysis 9. Future Opportunities

33. 9.1 Future Opportunities AI, machine learning and natural language processing tools can identify both clinical and socioeconomic data points to ensure patient support teams are spending time with the right patients, particularly with those who may be closer to nonadherence ▪ 33 A Sample Report on Australia Patient Support Program Market I Confidential

34. Australia Patient Support Program Market Analysis 10. Conclusion

35. 10.1 Conclusion Growing Technology Advancements With the emerging technology and the transformation from paper to digital, companies are offering virtual care to patients and HCPs Emerging Initiative Increasing pressure on the pharma companies to help patients with the access of their drugs is done through various initiatives Support for the HCPs Patient support programs are also assisting HCPs to deliver healthcare virtually with the comfort of being at their home during COVID-19 pandemic 3 2 4 Strong Demand With the implementation of government norms towards patient centricity there is an increase demand Advancement in healthcare delivery PSPs would enhance the way healthcare was delivered to the patient earlier, with new innovations coming up that will help to reduce the overall cost of treatment 5 1 35 A Sample Report on Australia Patient Support Program Market I Confidential

36. Methodology & Scope

37. Research Methodology Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources For forecasting, the following parameters are considered: ❑ Market drivers and restraints along with their current and expected impacts ❑ Technological scenario and expected developments ❑ End use industry trends and dynamics ❑ Trends in the consumer behavior ❑ Regulatory scenario and expected developments ❑ Current capacity and expected capacity additions up to 2030 We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time- sensitive, reflecting the most recent value and volume of the market across regions All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs) Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn) ▪ ▪ ▪ ▪ ▪ ▪ ▪ 37 A Sample Report on Australia Patient Support Program Market Analysis I Confidential

38. Analysis Methodology Our Analysis Methodology involves three critical stages: Market Data Analysis & Statistical Model Interpretation & Presentation Data Collection Analysis & Interpretation Market Trends Secondary Research Market Sizing & Analysis Insights Primary Research Presentation & Reporting Data Triangulation & Validation 38 A Sample Report on Australia Patient Support Program Market Analysis I Confidential

39. Data Triangulation & Data Validation Top Down Approach Final Market Size Final Market size break up to rest of segmentation Validation from Primary Interview Arriving at market size of each segment Summarization of revenue generated from companies to arrive at total market size Validation from Primary Interview Revenue generated by products & services offered by companies Final Summary Bottom Up Approach 39 A Sample Report on Australia Patient Support Program Market Analysis I Confidential

40. Key Benefits for Stakeholders from this Report Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on the prevailing market opportunities Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors 40 A Sample Report on Australia Patient Support Program Market Analysis I Confidential

41. Time Frame Report Attribute Details Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Base Year for Estimation 2021 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Company Profiles, Competitive Landscape, Regulatory Landscape, Future Opportunities Report Coverage Report Customization (5 working days) with purchase. We will provide you with data that is currently not a part of our scope as a part of customization Customized Report Forecast Period 2022- 2030 Pricing and purchase options Avail customized purchase options to meet your exact research needs

42. What kind of Data is Presented in this Report? This report presents data, which is: Expert-verified Real Comprehensive Easy to read Reliable The data is prepared by a team of highly qualified & experienced research analysts & vetted by our local associates Covers everything you would need to know about the market including market size, competitive analysis & much more You do not have to be a market expert to understand what really is happening on the market and how it works Allowing you to confidently make smarter business and strategic decisions The report is prepared using a proven methodology and insightful research www.insights10.com

43. About

44. Lifesciences Market Research Reports you can trust A large database of over 30,000 syndicated market research reports in pharmaceuticals and healthcare sector at global, regional as well as country level. We also provide customized research reports tailor made to suit your needs www.insights10.com

45. Get Insights to take informed Business Decisions Insights10 is a healthcare focused market research firm founded with an aim of being an insights driven company in the data driven world and delivering actionable insights that can drive decision and strategy making process for businesses www.insights10.com

46. Market Research Reports across various domains of healthcare Pharmaceuticals (Diseases & Drugs) Digital Health Medical Devices Healthcare Services OTC & Clinical Trials Nutraceuticals

47. 1 Full-Time Engagement 6 Market Research Reports Customized Reports 2 7 Conference Coverage Our 8 3 Primary Research Competitive Intelligence Services 4 Strategic Research Projects 9 Regulatory Compliance 10 5 Database Services Report Subscription Services

48. Our Research Process 01 02 03 04 05 Identification of Data Market Dynamics Collection of Data Collaboration of Data Verification & Analysis www.insights10.com

49. Statistical Databases Company Websites/Annual Reports Data Sources Trade Publications We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. Online Databases Published Research Reports Whitepapers Press Releases of Key Market Players www.insights10.com

50. Over the years, we have developed an in-depth experience of executing market analysis at global, regional & country specific level in life sciences. Our team has conducted market research across 62+ global markets in America, Europe, Middle East, Africa and Asia Pacific regions Research Projects Done